These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 10723751)

  • 21. Refining frontotemporal dementia with parkinsonism linked to chromosome 17: introducing FTDP-17 (MAPT) and FTDP-17 (PGRN).
    Boeve BF; Hutton M
    Arch Neurol; 2008 Apr; 65(4):460-4. PubMed ID: 18413467
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Hereditary frontotemporal dementia caused by Tau gene mutations.
    van Swieten J; Spillantini MG
    Brain Pathol; 2007 Jan; 17(1):63-73. PubMed ID: 17493040
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Explanatory note.
    Rabey JM
    Mov Disord; 2004 Jan; 19(1):117. PubMed ID: 14743377
    [No Abstract]   [Full Text] [Related]  

  • 24. SJLB mice develop tauopathy-induced parkinsonism.
    Takenokuchi M; Kadoyama K; Chiba S; Sumida M; Matsuyama S; Saigo K; Taniguchi T
    Neurosci Lett; 2010 Apr; 473(3):182-5. PubMed ID: 20178834
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Brain acetylcholinesterase activity in FTDP-17 studied by PET.
    Hirano S; Shinotoh H; Kobayashi T; Tsuboi Y; Wszolek ZK; Aotsuka A; Tanaka N; Ota T; Fukushi K; Tanada S; Irie T
    Neurology; 2006 Apr; 66(8):1276-7. PubMed ID: 16636254
    [No Abstract]   [Full Text] [Related]  

  • 26. Tau gene mutations in frontotemporal dementia and parkinsonism linked to chromosome 17 (FTDP-17). Their relevance for understanding the neurogenerative process.
    Goedert M; Ghetti B; Spillantini MG
    Ann N Y Acad Sci; 2000; 920():74-83. PubMed ID: 11193179
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The tau N279K exon 10 splicing mutation recapitulates frontotemporal dementia and parkinsonism linked to chromosome 17 tauopathy in a mouse model.
    Dawson HN; Cantillana V; Chen L; Vitek MP
    J Neurosci; 2007 Aug; 27(34):9155-68. PubMed ID: 17715352
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Frontotemporal dementia and parkinsonism linked to chromosome 17.
    Wszołek ZK; Słowiński J; Golan M; Dickson DW
    Folia Neuropathol; 2005; 43(4):258-70. PubMed ID: 16416390
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Frontotemporal dementia and parkinsonism linked to chromosome 17 (FTDP-17).
    Wszolek ZK; Tsuboi Y; Ghetti B; Pickering-Brown S; Baba Y; Cheshire WP
    Orphanet J Rare Dis; 2006 Aug; 1():30. PubMed ID: 16899117
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Clinical-pathologic study of biomarkers in FTDP-17 (PPND family with N279K tau mutation).
    Arvanitakis Z; Witte RJ; Dickson DW; Tsuboi Y; Uitti RJ; Slowinski J; Hutton ML; Lin SC; Boeve BF; Cheshire WP; Pooley RA; Liss JM; Caviness JN; Strongosky AJ; Wszolek ZK
    Parkinsonism Relat Disord; 2007 May; 13(4):230-9. PubMed ID: 17196872
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Reduced binding of protein phosphatase 2A to tau protein with frontotemporal dementia and parkinsonism linked to chromosome 17 mutations.
    Goedert M; Satumtira S; Jakes R; Smith MJ; Kamibayashi C; White CL; Sontag E
    J Neurochem; 2000 Nov; 75(5):2155-62. PubMed ID: 11032905
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A case of dementia parkinsonism resembling progressive supranuclear palsy due to mutation in the tau protein gene.
    Soliveri P; Rossi G; Monza D; Tagliavini F; Piacentini S; Albanese A; Bugiani O; Girotti F
    Arch Neurol; 2003 Oct; 60(10):1454-6. PubMed ID: 14568818
    [TBL] [Abstract][Full Text] [Related]  

  • 33. FTDP-17 tau mutations decrease the susceptibility of tau to calpain I digestion.
    Yen S; Easson C; Nacharaju P; Hutton M; Yen SH
    FEBS Lett; 1999 Nov; 461(1-2):91-5. PubMed ID: 10561502
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Frontotemporal dementia: tau mutations, deposition, and molecular mechanisms of neuronal cell death].
    Hasegawa M
    Rinsho Shinkeigaku; 2004 Nov; 44(11):879-81. PubMed ID: 15651320
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Visualization of MAPT inversion on stretched chromosomes of tau-negative frontotemporal dementia patients.
    Gijselinck I; Bogaerts V; Rademakers R; van der Zee J; Van Broeckhoven C; Cruts M
    Hum Mutat; 2006 Oct; 27(10):1057-9. PubMed ID: 16906510
    [No Abstract]   [Full Text] [Related]  

  • 36. Pick's complex and FTDP-17.
    Kertesz A
    Mov Disord; 2003 Sep; 18 Suppl 6():S57-62. PubMed ID: 14502657
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Frontotemporal lobar degeneration. An update on clinical, pathological and genetic findings.
    Tolnay M; Probst A
    Gerontology; 2001; 47(1):1-8. PubMed ID: 11244285
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Impairments in impulse control in mice transgenic for the human FTDP-17 tauV337M mutation are exacerbated by age.
    Lambourne SL; Humby T; Isles AR; Emson PC; Spillantini MG; Wilkinson LS
    Hum Mol Genet; 2007 Jul; 16(14):1708-19. PubMed ID: 17517691
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Frontotemporal dementia and parkinsonism linked to chromosome 17 (FTDP-17): PPND family. A longitudinal videotape demonstration.
    Wszolek ZK; Kardon RH; Wolters EC; Pfeiffer RF
    Mov Disord; 2001 Jul; 16(4):756-60. PubMed ID: 11481705
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Frontotemporal dementia--Part II. Differential diagnosis, genetics, molecular pathomechanism and pathology.
    Galariotis V; Bódi N; Janka Z; Kálmán J
    Ideggyogy Sz; 2005 Jul; 58(7-8):220-4. PubMed ID: 16173270
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.